Home
Drugs
fluorouracil
Clinical Trials

Clinical Trials Related to fluorouracil

Related studies linked through entity extraction aliases.

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Status: RECRUITING
Phase: PHASE2

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

Status: RECRUITING
Phase: PHASE2

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Status: RECRUITING
Phase: PHASE2

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Status: COMPLETED
Phase: PHASE1/PHASE2

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Status: RECRUITING
Phase: PHASE1

Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS

Status: NOT_YET_RECRUITING
Phase: PHASE2

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

Status: RECRUITING
Phase: PHASE1

CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

Status: NOT_YET_RECRUITING
Phase: PHASE2

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Status: RECRUITING
Phase: PHASE2

Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

Status: RECRUITING
Phase: PHASE2

The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Modified FOLFIRINOX (mFFX) or Gemcitabine Plus Nab-paclitaxel (GnP) Therapy as First-line Treatment in Patients With Metastatic Pancreatic Cancer

Status: COMPLETED
Phase: PHASE1

An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

Status: RECRUITING
Phase: PHASE2

The Sagittarius Trial

Status: RECRUITING
Phase: PHASE3

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Status: RECRUITING
Phase: PHASE2

Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

Status: RECRUITING
Phase: PHASE2/PHASE3

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2